Comparative treatment patterns, healthcare resource utilization and costs of atomoxetine and long-acting methylphenidate among children and adolescents with attention-deficit/hyperactivity disorder in Germany
Crossref DOI link: https://doi.org/10.1007/s10198-016-0836-8
Published Online: 2016-11-05
Published Print: 2017-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Greven, Peter
Sikirica, Vanja
Chen, Yaozhu J.
Curtice, Tammy G.
Makin, Charles
Funding for this research was provided by:
Shire Development LLC
License valid from 2016-11-05